Compass Therapeutics (CMPX)
$0.79 +4.01% Close Oct 30, 2026 Live
Compass Therapeutics stock today
Compass Therapeutics closed at $0.79 on October 30, 2026, up 4.01% on the day. Over the past year it returned -78.9% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $142 million.
$2.00$4.00$6.00
NovJan 2026MarMayJulSep
| Period | CMPX | S&P 500 (SPY) |
|---|---|---|
| 1 month | -24.4% | -0.9% |
| 3 months | -59.5% | +2.1% |
| Year to date | -85.4% | +11.7% |
| 1 year | -78.9% | +12.4% |
| 3 years | -55.6% | +88.5% |
| 5 years | -74.0% | +76.0% |
Key statistics
- Market value
- $142M
- 52-week range
- $0.75 to $6.69
- Next report
- Nov 5, 2026 (estimated)
About Compass Therapeutics
Compass Therapeutics is a clinical-stage biopharmaceutical company developing immuno-oncology and other targeted therapies.
Sector: Health Care
More on Compass Therapeutics
- Returns: what $1,000 became$1,000 five years ago is $260.43 today
No forecast, no recommendation. This page describes Compass Therapeutics from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.